Gov. Deval Patrick defended the state's first-in-the-nation ban of the powerful new painkiller Zohydro after a federal judge suggested in court that his administration may have overreached.
The SAM-1™ Smart Aqua Meter harnesses the convenience of handheld smart devices to measure and record pH, ORP, conductivity and temperature values.
Introducing a complete line of Shiseido HPLC Columns used for the analysis of vitamins.
Introducing a new instrument, the TPK-R™ critical flow controller model designed to improve the ergonomics of test set-up for dry powder inhaler (DPI) testing.
Integrated Project Services, Inc. (IPS) announced the expansion of operations with the opening of a new IPS location in Irvine, California.
Bacterin International Holdings, Inc. is pleased to announce the addition of Jimmy Bornheimer, Vice President of Finance, and Stephen Smith, Vice President of Regulatory and Quality Assurance.
Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa ® (dabigatran etexilate) for the treatment of DVT and PE in patients who have been treated with a parenteral (injectable) anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated.
A U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly and Co., to pay $9 billion in punitive damages over a diabetes medicine linked to cancer. The drug companies said Tuesday they will "vigorously challenge" the decision.
Teva Pharmaceutical Industries said Tuesday it is now selling a generic version of the heart medication Lovaza, which is used to treat high triglyceride levels.
The maker of Zohydro, a controversial new prescription painkiller, has filed a lawsuit in federal court seeking to block Massachusetts' ban on local doctors prescribing and dispensing the drug.
Arkansas Attorney General Dustin McDaniel asked the state Supreme Court on Monday to reconsider its decision tossing out a $1.2 billion judgment against drugmaker Johnson & Johnson, saying justices did "significant harm" to the state and broke from 170 years of precedent.
Pfizer and Questcor Pharmaceuticals were just a couple of the companies that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market.
Stocks are drifting mostly higher in early trading on Wall Street as the market stabilizes after a three-day slump.
Thanks to a high level of access to healthcare insurance and reimbursement, coupled with increasing demand for healthcare services from an expanding elderly population, the South Korean pharmaceutical market is expected to climb in value from $19.3 billion in 2013 to $24.3 billion by 2020.